Inhibins, activins and anti-Müllerian hormone: Structure, signalling pathways, actions and clinical relevance in assisted reproductive therapy;Inhibines, activines et hormone anti-Müllerienne: Structure, signalisation, rôles et valeur prédictive en médecine de la reproduction

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 11, 2003, Pages 900-911

  Deffieux, X ^a   Antoine, J M ^a  

^a HÔPITAL TENON   (France)

Author keywords

Activin; AMH (MIS); ART; Inhibin; IVF; Ovarian follicular reserve; Spermatogenesis; TESE; Testis

Indexed keywords

ACTIVIN; GLYCOPROTEIN; INHIBIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AZOOSPERMIA; CELL MATURATION; ENDOCRINE SYSTEM; GONAD TUMOR; GRANULOSA CELL; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS CELL; INFERTILITY THERAPY; OOCYTE; PARACRINE SIGNALING; PREGNANCY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPRODUCTION; REVIEW; SEMINAL PLASMA; SERTOLI CELL; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TESTICULAR SPERM EXTRACTION;

EID: 0344876580     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.08.012     Document Type: Short Survey

References (125)

1. Bernard DJ, Chapman SC, Woodruff TK. An emerging role for co-receptors in inhibin signal transduction. Mol Cell Endocrinol 2001;180(1-2):55-62.
2. Bernard DJ, Chapman SC, Woodruff TK. Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor. Mol Endocrinol 2002;16(2):207-12.
3. Illingworth PJ, Groome NP, Byrd W, Rainey WE, McNeilly AS, Mather JP, et al. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996;81: 1321-5.
4. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly AS, et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341-5.
5. Anderson RA, Irvine DS, Balfour C, Groome NP, Riley SC. Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. Hum Reprod 1998;13:920-6.
6. Namiki M, Kondoh N, Matsumiya K, Sakoda S, Nishimune Y, Okuyama A. Hormonal regulation of human testicular inhibin α and βB subunit messenger RNAs. J Urol 1993:150:1007-9.
7. Klaij IA, van Pelt AMM, Timmerman MA, Blok LJ, de Rooij DG, de Jong FH. Expression of inhibin subunit mRNAs and inhibin levels in the testes of rats with stage-synchronized spermatogenesis. J Endocrinol 1994;141:131-41.
8. Andersson AM, Muller J, Skakkebaek NE. Different roles of prepubertal and post-pubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab 1998;83: 4451-8.
9. Crofton PM, Evans AEM. Groome NP, Taylor MRH, Holland CV, Kelnar CJH. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol 2002; 56:223-30.
10. Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men J Clin Endocrinol Metab 1999;82:4059-63.
11. Pierik FH, Vreeburg JT, Stijnen T, De Jong FH, Weber RF. Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 1998;83:3110-4.
12. Bohring C, Krause W. Serum levels of inhibin B in men with different causes of spermatogenic failure. Andrologia 1999;31:137-41.
13. Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G. Effects of human recombinant luteinizing hormone and follicole-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J Clin Endocrinol Metab 2000;85:3239-44.
14. Hayes FJ, Pitteloud N, DeCruz S, Crowley WF, Boepple PA. Importance of inhibin B in the regulation of FSH secretion in the human male. J Clin Endocrinol Metab 2001;86:5541-6.
15. Carlsen E, Olsson C, Petersen JH, Andersson AM, Skakkebaek NE. Diurnal rhythm in serum levels of inhibin B in normal men: relation to testicular steroids and gonadotropins. J Clin Endocrinol Metab 1999; 84:1664-9.
16. Klein NA, Illingworth PJ, Groome NP, McNeily AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81:2742-5.
17. Burger HG, Groome NP, Robertson DM. Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 1998; 83:4167-9.
18. Fraser HM, Groome NP, McNeilly AS. Follicle-stimulating hormone-inhibin B interactions during the follicular phase of the primate menstrual cycle revealed by gonadotropin-releasing hormone antagonist and anti-estrogen treatment. J Clin Endocrinol Metab 1999;84: 1365-9.
19. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1404-5.
20. Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG. Serum concentration of dimeric inhibin during spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod 1994;9:1634-42.
21. Sehested A, Juul A, Andersson AM. Petersen JH, Jensen TK, Müller J, et al. Serum inhibin A and inhibin B in healthy pre-pubertal, pubertal, and adolescent girls and adult women: Relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 2000;85: 1634-40.
22. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 2001;86:330-6.
23. Vitale AM, Gonzalez OM, Parborell F, Irusta G, Campo S, Tesone M. Inhibin A increases apoptosis in early ovarian antral follicles of diethylstilbesterol-treated arts. Biol Reprod 2002;67:1989-95.
24. Wang HS, Wang TH, Soong YK. Cyclic changes in serum levels of insulin-like growth factor binding protein-1 in women treated with clomiphene citrate and tamoxifen. Gynecol Endocrinol 2000;14:236-44.
25. Bahathik AO, Stewart RL, Wells M, Moore MD, Pacey AA, Ledger WL. Production of activins by the human endosalpinx. J Clin Endocrinol Metab 2002;87:5283-9.
26. De Kretser DM, Hedger MP, Loveland KL, Phillips DJ. Inhibins, activins and follistatin in reproduction. Hum Reprod Update 2002;8: 529-41.
27. Reame NE, Wyman TL, Phillips DJ, de Krester DM, Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J ClinEndocrinolMetab 1998;83:3302-7.
28. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, et al. Serum inhibin A and B fall differentially as FSH rises in perimenopausal women. Clin Endoc 1998;48:809-13.
29. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-11.
30. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999;71:658-62.
31. Muttukrishna S, Child T, Lockwood GM, Groome NP, Barlow DH, Ledger WL. Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women. Hum Reprod 2000; 15:549-56.
32. Menon U, Riley SC, Thomas J, Bose C, Dawnay A, Evans LW, et al. Serum inhibin, activin and follistatin in post menopausal women with epithelial carcinoma. BJOG 2000;107:165-9.
33. Muttukrishna S, Sharma S, Barlow DH, Ledger W, Jivraj S, Groome N, et al. Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women. Hum Reprod 2002;17:2535-9.
34. McLachlan RI, Dahl KD, Bremner WJ, Schwall R, Schmelzer CH, Mason AJ, et al. Recombinant human activin A stimulates basal FSH and GnRH-stimulated FSH and LH release in the adult male macaque. Macaca fascicularis. Endocrinology 1989;125:12787-9.
35. Stuffer RL, Woodruff TK, Dahl KD, Hess DL, Mather JP, Molskness TA. Human recombinant activin A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis during the menstrual cycle in rhesus monkeys. J Clin Endocrinol Metab 1993;77:241-8.
36. Muttukrishna S, Fowler PA, George L, Groome NP, Knight PG. Changes in peripheral serum lvels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 1996;81: 3328-34.
37. Woodruff TK. Regulation of cellular and system function by activin. Biochem Pharmacol 1998;55:953-63.
38. De Jong FH. Testicular activin - to hot to handle? Eur J Endocrinol 1997;137:448-9.
39. Meinhardt A, McFarlane JR, Seitz J, de Kretser DM. Activin maintains the condensed type of mitochondria in germ cells. Mol Cell Endocrinol 2000; 186:111-7.
40. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL, Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin-follistatin autocrine or paracrine loop. Endocrinology 1996;137:3667-73.
41. Casper FW, Seufert RJ, Schaffrath M, Pollow K. Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment. Fertil Steril 2001;75:32-7.
42. Rabinovici J, Goldsmith PC, Roberts VJ, Vaughan J, Vale W, Jaffe RB. Localization and secretion of inhibin-activin subunits in the human and subhuman primate fetal gonads. J Clin Endocrinol Metab 1991; 73:1141-9.
43. Miro F, Hillier SG. Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology 1996; 137:464-8.
44. Xiao S, Robertson DM, Findlay JK. Effects of activin and follicle-stimulating hormone (FSH)-suppressing protein-follistatin on FSH receptors and differentiation of cultured rat granulosa cells. Endocrinology 1992;131:1009-16.
45. Mizunuma H, Liu XW, Andoh K, Abe Y, Kobayashi J, Yamada K, et al. Activin from secondary follicles causes small pre-antral follicles to remain dormant at the resting stage. Endocrinology 1999; 140:37-42.
46. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab 1991;72:1206-11.
47. Yoshioka K, Kamomae H. Recombinant human activin A stimulates development of bovine one-cell embryos matured and fertilized in vitro. Mol Reprod Dev 1996;45:151-6.
48. Yoshioka K, Takada M, Taniguchi T, Yamanaka H, Sekikawa K. Differential expression of activin subunits, activin receptors and follistatin genes in bovine oocytes and pre-implantation embryos. Reprod Fertil Dev 1998; 10:293-8.
49. Silva CC, Knight PG. Modulatory actions of activin A and follistatin on the developmental competence of in-vitro matured bovin oocytes. Biol Reprod 1998;58:558-65.
50. Sadatsuki M, Tsutsumi O, Yamada R, Muramatsu M. Taketani Y. Local regulatory effects of activin A and follistation on meiotic maturation of rat oocytes. Biochem Biophys Res Commun 1993; 196:388-95.
51. Alak BM, Coskun S, Friedman CI, Kennard EA, Kim MH, Seifer DB. Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertil Steril 1998;70: 1126-30.
52. Jones RL, Salamonsen LA, Findlay JK. Activin A promotes human endometrial cell decidualization in vitro. J Clin Endocrinol Metab 2002;87:4001-4.
53. Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, et al. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 1991:128:1682-4.
54. Bilezikjian LM, Corrigan AZ, Blount AL, Vale WW. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels and differentially regulated by local and hormonal factors. Endocrinology 1996; 137:4277-84.
55. Mahmoud AM, Comhaire FH, Depuydt CE. The clinical and biologic significance of serum inhibins in subfertile men. Reprod Toxicol 1998;12:591-9.
56. Kolb BA, Stanczyk FZ, Sokol RZ. Serum inhibin B levels in males with gonadal dysfunction. Fertil Steril 2000;74:234-8.
57. Ballesca JL, Balasch J, Calafell JM, Alvarez R, Fabregues F, de Osaba MJ, et al. Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod 2000;15:1734-8.
58. Von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF. Gassner P, Schepers AG, et al. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 1999;84:2496-501.
59. Brugo-Olmedo S, de Vincentiis S, Calamera JC, Urrutia F, Nodar F, Acosta AA. Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with non-obstructive azoospermia. Fertil Steril 2001;76:1124-9.
60. Vernaeve V, Tournaye H, Schiettecatte J, Verheyen G, van Steirteghem A, Devroey P. Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia. Hum Reprod 2002;17:971-6.
61. Guthauser B. Bailly M. Bergere M, Wainer R, Ville Y, Selva J Successful pregnancy and delivery after testicular sperm extraction despite an undetectable concentration of serum inhibin B in a patient with non-obstructive azoospermia Fertil Steril 2002;77:1077-8.
62. El Garem YF, El Arini AF, El Beheiry AH, Abou Zeid SA, Comhaire FH. Possible relationship between seminal plasma inhibin B and spermatogenesis in patients with azoospermia. J Androl 2002;23: 825-9.
63. Seifer DB, Messerlian L, et al. Day 3 serum inhibin B is predictive of ART outcome. Fertil Steril 1997;67:110-4.
64. Hayes FJ, Hall JE, Boepple PA, Crowley WF. Clinical review 96: differential control of gonadotropin secretion in the human: endocrine role of inhibin. J Clin Endocrinol Metab 1998;83:1835-41.
65. Eldar-Geva T, Robertson DM, Cahir N, Groome N, Gabbe MP, Maclachlan V, et al. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J Clin Endocrinol Metab 2000;85:607-13.
66. Hall JE, Welt CK, Cramer DW. Inhibin A and B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14:409-15.
67. Corson SL, Gutmann J, Batzer FR, Wallace H, Klein N, Soules MR, et al. Inhibin B as a test of ovarian reserve for infertile women. Hum Reprod 1999;14:2818-21.
68. Eldar-Geva T, Margalioth EJ, Ben-Chetrit A, Gal M, Robertson DM, Healy DL, et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod 2002;17:2331-7.
69. Pennarubia J, Balash J, Fabregues F, Carmona F, Casamitjana R, Moreno V, et al. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome agonist-gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod 2000;15:1499-504.
70. Fawzy M, Lambert A, Harrison RF, Knight PG, Groome N, Hennelly B, et al. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum Reprod 2002;17:1535-43.
71. Chang CL, Wang T-H, Horng SG, Wu H-M, Wang H-S, Soong Y-K. The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development. Hum Reprod 2002;17:1724-8.
72. Lockwood GM, Ledger WL, Barlow DH, Groome NP, Muttukrishna S. Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy. Am J Reprod Immunol 1998;40:303-8.
73. Millot F, Antoine JM, Merviel P, Mathieu E, Capeau J, Uzan S. Comparaison des valeurs prédictives des inhibines A et B, et de l'estradiol plasmatiques chez des patientes traitées en vue de FIV par agoniste du GnRH et FSH recombinante. Gynécol Obstét Fertil 2002; 30:36-41.
74. Birdsall M, Ledger W, Groome N, Abdalla H, Muttukrishna. Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab 1997;82:1557-60.
75. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro-alpha C containing inhibins and activin A in early pregnancy. Hum Reprod 1997;12:1089-93.
76. Keelan JL, Groome N, Mitchell M. Regulation of activin A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines. Placenta 1998;19:429-34.
77. Riley SC, Leask R, Brennand JE, Balfour C, Brenand JE, Groome NP. Production of inhibin forms by the foetal membranes, decidua, placenta and fetus at parturition. Hum Reprod 2000; 15:578-83.
78. Treetampinick C, O'Connor AE, MacLachlan V, Groome NP, de Krester D. Maternel serum inhibin A concentrations in early pregnancy after embryo transfer reflect the corpus luteum. Hum Reprod 2000; 15:2028-32.
79. Mohan A, Asselin J, Sargent IL, Groome NP, Muttukrishna S. Effect of cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term placental villous trophoblasts in culture. Eur J Endocrinol 2001;145:505-11.
80. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotophoblasts cell differenciation. Endocrinology 1997;138:3976-86.
81. Lockwood GM, Muttukrishna S, Groome NP, Knight PG, Ledger WL. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin Endoncrinol 1996;45: 741-8.
82. Muttukrishna S, Jauniaux E, Greenwold N, McGarrigle H, Jivraj S, Carter S, et al. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 2002;17:3072-8.
83. Florio P, Cobellis L, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 2001;180:123-30.
84. Steger K, Rey R, Kliesch S, Louis F, Schleicher G, Bergmann M. Immunohistochemical detection of immature Sertoli cell markers in testicular tissue of infertile adult men: a preliminary study. Int J Androl 1996;19:122-8.
85. Cohen-Haguenauer O, Picard JY, Mattei MG, Serero S, Nguyen VC, de Tand MF, et al. Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987; 44:2-6.
86. Fénichel P, Rey R, Poggioli S. AMH as a seminal marker of spermatogenesis in non-obstructive azoospermia. Hum Reprod 1999;2020: 2024.
87. Rey RA, Belville C, Nihoul-Fékété C, Michel-Calemard L, Forest MG, Lahlou N, et al. Evaluation of Gonadal Function in 107 Inter-sex Patients by Means of Serum Anti-müllerian Hormone Measurement. J Clin Endocrinol Metab 1999;84:627-31.
88. De Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-Müllerian hormone serum levels: a putative marker of ovarian aging. Fertil Steril 2002;77:357-62.
89. Rey R, Lordereau-Richard I, Carel JC, Barbet P, Cate RL, Roger M, et al. Anti-Müllerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development. JCEM 1993;77:12206.
90. Rey R, Mebarki F, Forest MG, Mowszowicz I, Cate RL, Morel Y, et al. Anti-Müllerian hormone in children with androgen insensivity. JCEM 1994;79:960-4.
91. Al-Attar L, Noël K, Dutertre M, Belville C, Forest MG, Burgoyne PS, et al. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J Clin Invest 1997;100:1335-43.
92. Vigier B, Picard JY, Tran D, Legeai L, Josso N. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 1984;114:1315-20.
93. Ueno S, Kuroda T, MacLaughlin DT, Ragin RC, Manganaro TF, Donahoe PK. Müllerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology 1989;125: 1060-6.
94. Munsterberg A, Lovell-Badge R. Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 1991;113:613-24.
95. Hirobe S, He WW, Lee MM, Donahoe PK. Müllerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 1992; 131:854-62.
96. Taketo T, Saeed J, Manganaro T, Takahashi M, Donahoe PK. Müllerian inhibiting substance production associated with loss of oocytes and testicular differentiation in the transplanted mouse XX gonadal primordium. Biol Reprod 1993;49:13-23.
97. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002; 143(3):1076-84.
98. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugger JW, van Leeuwen EC, Themmen AP, et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle and gonadotropin-induced follicle growth. Endocrinology 1995;136:4951-62.
99. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, et al. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Human Pathol 2000;31:1202-8.
100. Bezard J, Vigier B, Tran D, Mauleon P, Josso N. Anti-müllerian hormone in sheep follicles. Reprod Nutr Dev 1988;28(4B):1105-12.
101. Thibault E, Mirallié S, Jean M, Bouchot O, Barrière P. Hormone anti-müllerienne séminale: un possible marqueur de la spermatogenèse dans les azoospermies non obstructives. XIX congrès de la Société d'andrologie de langue française. Genève. Décembre 2002.
102. Massagué J. TGF-β signal transduction. Annu Rev Biochem 1998;67: 753-91; Reproduction 2001;64:293-8.
103. Massagué J. TGF-β signal transduction. Annu Rev Biochem 1998;67: 753-91; Reproduction 2001;64:293-8.
104. Josso N, di Clemente N, Gouedard L. Anti-Müllerian hormone and its receptor. Mol Cell Endocrinol 2001;179:25-32.
105. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, et al. Genetic analysis of the anti-Müllerian substance signal transduction pathway in mammalian sexual differentiation. Genes and Development 1996;10:2577-85.
106. Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, di Clemente N, Josso N, et al. A 27 base-pair deletion of the anti-Müllerian hormone type II receptor gene is the most common cause of the persistent Müllerian duct syndrome. Human Molecular Genetics 1996;5:1269-77.
107. Dewulf N, Verschueren K, Lonnoy O, Moren A, Grimsby S, Vande Spiegle K, et al. Distinct spatial and temporal expression patterns of two type I receptors of bone morphogenetic proteins during mouse embryogenesis. Endocrinology 1995;136:2652-63.
108. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA. The serine-threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol Endocrinol 2001; 15:936-45.
109. Jamin SP, Arango NA, MishinaY, Hanks MC, Behringer RR. Requirement of Bmprla for Mullerian duct regression during male sexual development. Nat Genet 2002;32:408-10.
110. Jost A. Recherches sur la différenciation sexuelle de l'embryon de lapin. Arch Anat Microsc Morphol Exp 1947;36:271-315.
111. Behringer RR, Finegold MJ, Cate RL. Müllerian inhibiting substance function during mammalian sexual development. Cell 1994;79:415-25.
112. Racine C, Rey R, Forest MG, Louis F, Ferré A, Huhtaniemi I, et al. Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 1998;95:594-9.
113. Cazorla O, Seck M. AMH secretion in pre-pubertal and adult rams. J Reprod Fertil 1998;112:259-66.
114. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999; 140:5789-96.
115. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001; 142: 4891-9.
116. Di Clemente N, Wilson C, Faure E, et al. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 1994;8:1006-20.
117. McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H, Hsueh AJ. Müllerian inhibiting substance induces growth of rat pre-antral ovarian follicles. Biology of.
118. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002; 124:601-9.
119. Tsafriri A, Picard JY, Josso N. Immunopurified anti- Müllerian hormone does not inhibit spontaneous resumption of meiosis in vitro of rat oocytes. Biology of Reproduction 1998;38:481-5.
120. Fujisawa M, Yamasaki T, Okada H, Kamidono S. The signifiance of anti-Müllerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod 2002; 17:968-70.
121. Te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update 2002;8:141-54.
122. De Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE, et al. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-85.
123. Nikolaou D, Lavery S, Turner C, Margara R, Trew G. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 2002; 17:1106-11.
124. Van Rooij IAJ, Broekmans FJM, de Velde ER, Fauser BCJM, Bancsi LFJMM, de Jong FH, et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002; 17 (12): 3065-71.
125. Seifer DB, MacLaughlin DT, Christian BP. Feng B, Shelden RM. Early follicular serum Müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468-71.